Skip to main content

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Identificación de factores de riesgo en el Trastorno por Déficit de Atención con Hiperactividad (TDAH) a través del estudio del perfil de metilación de ADN a escala genómica

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, Iris Garcia Martínez, Vanesa Richarte Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI14/01700
Duration: 01/01/2015 - 31/12/2018

Identification of biomarkers for Attention Deficit/Hyperactivity Disorder (ADHD): Analysis of microRNA expression profiles (miRNA trascriptome) through high-throughput next generation sequencing

IP: Marta Ribases Haro
Collaborators: -
Funding agency: Brain & Behavior Research Foundation
Funding: 58581.84
Reference: BMADHD_NARSAD2014
Duration: 15/01/2015 - 14/01/2018

MiND: Mastering skills in the training Network for attention deficit hyperactivity and autism spectrum Disorders

IP: José Antonio Ramos Quiroga
Collaborators: Marta Ribases Haro
Funding agency: EUROPEAN COMMISSION
Funding: 100194.48
Reference: MIND_H2020-MSCA-ITN2013
Duration: 01/01/2015 - 31/12/2018

Psiquiatria, Salut Mental i Addicions (GRC)

IP: Miquel Casas Brugué
Collaborators: Núria Gómez Barros, Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 27000
Reference: 2014 SGR 1357
Duration: 01/01/2014 - 31/12/2016

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Edoardo Caronna

Edoardo Caronna

Postdoctoral researcher
Headache and Neurological Pain
Read more
Selen Ozkan

Selen Ozkan

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Pediatric Neurology
Read more
Tamara Garcia Antolinez

Tamara Garcia Antolinez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.